Category: E-Books

Vaccination Strategies Against Highly Variable Pathogens - eBook
Sale!
Original price was: $116.70.Current price is: $12.00. $0.00
Given its scope, Vaccination Strategies Against Highly Variable Pathogens, (PDF) will appeal to scientists in the fields of infectious diseases, microbiology, and medicine. Vaccines against antigenically stable pathogens, or pathogens that are only present in a limited number of serotypes, have been very effective in the past and have drastically
Managing and Using Information Systems: A Strategic Approach (6th Edition) - eBook
Sale!
Original price was: $76.80.Current price is: $11.00. $0.00
Managing and Using Information Systems: A Strategic Approach, 6th Edition, (PDF) conveys the knowledge and insights MBA students need to become active and knowledgeable participants in information systems decisions. This textbook is written to assist managers to begin to form and point of view of how information systems will help,
witte statistics 11th ed
Sale!
Original price was: $38.80.Current price is: $5.00. $0.00
Drawing upon over forty years of experience, Robert S. Witte and John S. Witte, the authors of Statistics, 11th Edition (PDF) provide business professionals with a clear and methodical approach to essential statistical procedures. The etextbook clearly explains the basic concepts and procedures of descriptive and inferential statistical analysis. It features
Calculus for the Life Sciences (2nd Edition-Global) - eBook
Sale!
Original price was: $106.00.Current price is: $15.00. $0.00
Calculus for the Life Sciences, 2nd Global Edition (PDF) includes interesting, relevant applications that motivate students and emphasize the utility of mathematics for the life sciences. This 2nd edition (Global) also includes new ways to engage university students with the material, like Your Turn exercises. The MyMathLab® course for the
Tumor Immunology and Immunotherapy (Illustrated Edition) - eBook
Sale!
Original price was: $220.52.Current price is: $33.00. $0.00
Patients are starting to benefit from antibody-based, cellular, and vaccine approaches that are useful against genetically varied and therapy-resistance cancers. BCG immunotherapy is now being used as a first-line treatment for human bladder cancer and the introduction of prophylactic vaccination against HPV cancers and Hepatitis B is starting to show